Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 198
2 121.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd
Total Other Income
Caplin Point Laboratories Ltd
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
|
Total Other Income
₹738m
|
CAGR 3-Years
31%
|
CAGR 5-Years
28%
|
CAGR 10-Years
35%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Other Income
₹8.2B
|
CAGR 3-Years
38%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Other Income
₹7.8B
|
CAGR 3-Years
42%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Other Income
₹15.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Other Income
₹942.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-4%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Total Other Income
₹1.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Caplin Point Laboratories Ltd
Glance View
Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Chennai, Tamil Nadu. The firm is producing, developing and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals, and sachets (liquids and powders). The company also manufactures a range of ointments, creams, gels and lotions. The Company’s principal research and development facilities are located in Tamil Nadu, India. Its principal manufacturing facility is located in Puducherry, India. The Company’s subsidiaries include Caplin Point Far East Limited, Caplin Point (S) PTE Ltd, Caplin Steriles Limited and Caplin Point Laboratories Colombia SAS.
See Also
What is Caplin Point Laboratories Ltd's Total Other Income?
Total Other Income
738m
INR
Based on the financial report for Sep 30, 2024, Caplin Point Laboratories Ltd's Total Other Income amounts to 738m INR.
What is Caplin Point Laboratories Ltd's Total Other Income growth rate?
Total Other Income CAGR 10Y
35%
Over the last year, the Total Other Income growth was 27%. The average annual Total Other Income growth rates for Caplin Point Laboratories Ltd have been 31% over the past three years , 28% over the past five years , and 35% over the past ten years .
You don't have any saved screeners yet
